MicroRNAs as important players in regulating cancer through PTEN/PI3K/AKT signalling pathways

Cancer being the leading cause of mortality has become a great threat worldwide. Current cancer therapeutics lack specificity and have side effects due to a lack of understanding of the molecular mechanisms and signalling pathways involved in carcinogenesis. In recent years, researchers have been fo...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta. Reviews on cancer Vol. 1878; no. 3; p. 188904
Main Authors Selvakumar, Sushmaa Chandralekha, Preethi, K. Auxzilia, Sekar, Durairaj
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.05.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cancer being the leading cause of mortality has become a great threat worldwide. Current cancer therapeutics lack specificity and have side effects due to a lack of understanding of the molecular mechanisms and signalling pathways involved in carcinogenesis. In recent years, researchers have been focusing on several signalling pathways to pave the way for novel therapeutics. The PTEN/PI3K/AKT pathway is one of the important pathways involved in cell proliferation and apoptosis, leading to tumour growth. In addition, the PTEN/PI3K/AKT axis has several downstream pathways that could lead to tumour malignancy, metastasis and chemoresistance. On the other hand, microRNAs (miRNAs) are important regulators of various genes leading to disease pathogenesis. Hence studies of the role of miRNAs in regulating the PTEN/PI3K/AKT axis could lead to the development of novel therapeutics for cancer. Thus, in this review, we have focused on various miRNAs involved in the carcinogenesis of various cancer via the PTEN/PI3K/AKT axis. •MicroRNAs (miRNAs) are important modulators of gene expression and suppression in various diseases including cancer.•PTEN is an important tumour suppressor mechanism and is involved in the carcinogenesis of various cancer.•miRNAs regulating PTEN/PI3K/AKT signalling axis are potential biomarkers and therapeutic targets in cancer.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0304-419X
1879-2561
DOI:10.1016/j.bbcan.2023.188904